Shionogi & Co., Ltd. (OTCMKTS:SGIOF – Get Free Report) shares passed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $19.03 and traded as high as $20.85. Shionogi & Co., Ltd. shares last traded at $20.85, with a volume of 100 shares changing hands.
Shionogi & Co., Ltd. Trading Up 22.3%
The firm’s fifty day moving average is $17.84 and its 200 day moving average is $19.03.
Shionogi & Co., Ltd. Company Profile
Shionogi & Co, Ltd. is a Japanese pharmaceutical company headquartered in Osaka. Founded in 1878, the company researches, develops, manufactures and markets prescription medicines, with a focus on addressing infectious diseases and other significant unmet medical needs.
Its portfolio and development programs have included treatments for infectious diseases, central nervous system conditions, pain and other therapeutic areas. Shionogi is known for products such as Xofluza (baloxavir marboxil), an influenza treatment, and Fetroja (cefiderocol), an antibiotic for certain difficult-to-treat bacterial infections.
Featured Stories
- Five stocks we like better than Shionogi & Co., Ltd.
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
